Subsequently, pharmacological inhibition of PLK1 with BI-2536 and AURKA with alisertib resulted in a 5 to 9-fold decrease in BI-2536 IC50 values in SCLC cell lines (Fig. 2B). Here, AURKA is linked to small cell lung carcinoma.